AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteAmrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageAmrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageAmrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageAmrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageAmsacrine (m-AMSA) is an anticancer agent that displays activity against refractory acute leukemias as well as Hodgkin’s and non-Hodgkin’s lymphomas.
More Information Supplier PageAmsacrine (m-AMSA) is an anticancer agent that displays activity against refractory acute leukemias as well as Hodgkin’s and non-Hodgkin’s lymphomas.
More Information Supplier PageAmsacrine (m-AMSA) is an anticancer agent that displays activity against refractory acute leukemias as well as Hodgkin’s and non-Hodgkin’s lymphomas.
More Information Supplier PageAmsacrine (m-AMSA) is an anticancer agent that displays activity against refractory acute leukemias as well as Hodgkin’s and non-Hodgkin’s lymphomas.
More Information Supplier PageAmsilarotene (TAC-101) is a retinobenzoic acid with potential antineoplastic activity.
More Information Supplier PageAmsilarotene (TAC-101) is a retinobenzoic acid with potential antineoplastic activity.
More Information Supplier PageAmsilarotene (TAC-101) is a retinobenzoic acid with potential antineoplastic activity.
More Information Supplier PageAmsilarotene (TAC-101) is a retinobenzoic acid with potential antineoplastic activity.
More Information Supplier PageAmygdalin is a glycoside initially isolated from the seeds of the tree Prunus dulcis. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells.
More Information Supplier PageAmygdalin is a glycoside initially isolated from the seeds of the tree Prunus dulcis. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells.
More Information Supplier PageAmygdalin is a glycoside initially isolated from the seeds of the tree Prunus dulcis. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells.
More Information Supplier PageAmygdalin is a glycoside initially isolated from the seeds of the tree Prunus dulcis. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells.
More Information Supplier PageAmyloid b-Peptide (1-40) (human) is a peptide processed from the amyloid precursor protein (APP).
More Information Supplier PageAmyloid b-Peptide (1-40) (human) is a peptide processed from the amyloid precursor protein (APP).
More Information Supplier PageAmyloid b-Peptide (1-40) (human) is a peptide processed from the amyloid precursor protein (APP).
More Information Supplier PageAmyloid beta (A?? or Abeta) is a peptide of 36?C43 amino acids that is processed from the Amyloid precursor protein.
More Information Supplier PageAmyloid b-Peptide (1-43) (human), amyloid ?? peptide fragment. Highly toxic, showing higher neurotoxicity compared to A??40 and A??42.
More Information Supplier PageAmyloid b-Peptide (1-43) (human), amyloid ?? peptide fragment. Highly toxic, showing higher neurotoxicity compared to A??40 and A??42.
More Information Supplier PageAmyloid b-Peptide (10-20) (human), soluble amyloid b-peptide fragment that is a substrate for gelatinase A/type IV collagenase/MMP-2 and APP secretase; cleaved between Lys16 and Leu17.
More Information Supplier PageAmyloid b-Peptide (12-28) (human), amyloid b-peptide fragment; minimum section required to bind to brain proteins.
More Information Supplier PageAmyloid b-Peptide (12-28) (human), amyloid b-peptide fragment; minimum section required to bind to brain proteins.
More Information Supplier PageAmyloid b-Peptide (12-28) (human), amyloid b-peptide fragment; minimum section required to bind to brain proteins.
More Information Supplier PageAmyloid b-peptide (25-35) (human), fragment of human amyloid ??-peptide, functionally required for the neurotrophic and neurotoxic effects associated with Alzheimer’s disease.
More Information Supplier PageAmyloid b-peptide (25-35) (human), fragment of human amyloid ??-peptide, functionally required for the neurotrophic and neurotoxic effects associated with Alzheimer’s disease.
More Information Supplier PageAmyloid b-peptide (25-35) (human), fragment of human amyloid ??-peptide, functionally required for the neurotrophic and neurotoxic effects associated with Alzheimer’s disease.
More Information Supplier PageAmyloid b-peptide (42-1) (human), inactive control for Amyloid b (1-42) peptide.
More Information Supplier PageBeta-amyloid protein (A beta), a 39-43 amino acid peptide composed of a portion of the transmembrane domain and the extracellular domain of the amyloid precursor protein (APP), is also the principal component of amyloid.
More Information Supplier PageBeta-amyloid protein (A beta), a 39-43 amino acid peptide composed of a portion of the transmembrane domain and the extracellular domain of the amyloid precursor protein (APP), is also the principal component of amyloid.
More Information Supplier PageBeta-amyloid protein (A beta), a 39-43 amino acid peptide composed of a portion of the transmembrane domain and the extracellular domain of the amyloid precursor protein (APP), is also the principal component of amyloid.
More Information Supplier PageAN-2690, an antifungal agent with activity against Trichophyton species, in a topical solution formulation, for the potential treatment of onychomycosis.
More Information Supplier PageAN-2690, an antifungal agent with activity against Trichophyton species, in a topical solution formulation, for the potential treatment of onychomycosis.
More Information Supplier PageAN-2690, an antifungal agent with activity against Trichophyton species, in a topical solution formulation, for the potential treatment of onychomycosis.
More Information Supplier PageAN2728 is a topically administered, boron-containing, anti-inflammatory compound that inhibits PDE4 activity and thereby suppresses the release of TNFalpha, IL-12, IL-23 and other cytokines
More Information Supplier PageAN2728 is a topically administered, boron-containing, anti-inflammatory compound that inhibits PDE4 activity and thereby suppresses the release of TNFalpha, IL-12, IL-23 and other cytokines
More Information Supplier PageAN2728 is a topically administered, boron-containing, anti-inflammatory compound that inhibits PDE4 activity and thereby suppresses the release of TNFalpha, IL-12, IL-23 and other cytokines
More Information Supplier PageAN2728 is a topically administered, boron-containing, anti-inflammatory compound that inhibits PDE4 activity and thereby suppresses the release of TNFalpha, IL-12, IL-23 and other cytokines
More Information Supplier PageANA-12 is a TrkB receptor antagonist that demonstrates a 2-site mode of action, preventing activation by BDNF non-competitively.
More Information Supplier PageANA-12 is a TrkB receptor antagonist that demonstrates a 2-site mode of action, preventing activation by BDNF non-competitively.
More Information Supplier PageANA-12 is a TrkB receptor antagonist that demonstrates a 2-site mode of action, preventing activation by BDNF non-competitively.
More Information Supplier PageAnacardic Acid is a potent inhibitor of p300 and p300/CBP-associated factor histone acetyltranferases.
More Information Supplier PageAnacardic Acid is a potent inhibitor of p300 and p300/CBP-associated factor histone acetyltranferases.
More Information Supplier PageAnacardic Acid is a potent inhibitor of p300 and p300/CBP-associated factor histone acetyltranferases.
More Information Supplier PageAnacetrapib (MK-0859) is a CETP inhibitor being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.
More Information Supplier Page
